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Purpose/Aims: The purpose of this descriptive, correlational, cross-sectional study was 
to examine the relationships among perinatal mood and anxiety disorder (PMAD) 
symptomatology, select demographics, stigma of mental illness, and social support, 
among inpatient postpartum women.   
Rationale: PMADs affect as many as 21% of childbearing women, yet these disorders 
are identified and treated less than half the time. There is a gap in the literature regarding 
the relationships among stigma, social support, and PMADs in postpartum women.  
Conceptual Basis/Background: Despite recommendations from professional 
organizations, screening for PMADs is not consistently completed using a valid, reliable 
instrument. Stigma contributes to the low rate of identification and treatment. Extant 
research shows an inverse relationship between high levels of social support and 
PMADs, possibly mitigating the effects of stigma. 
Findings: A sample of 105 participants was divided into a low risk group (Group A) 
and a high-risk group (Group B) based on a score of >10 on the Edinburgh Postnatal 
Depression Scale (EPDS) or the Generalized Anxiety Disorder 7-item (GAD-7) 
screening instruments.  There were significant differences between groups for marital 
status (p=.01) with a higher percentage in Group A who were married and significant 
differences between groups for stigma (p=.002), with higher stigma for Group B 
participants.  Social support measurements were also significantly different between 
groups (p<.001), with higher social support in Group A. Current hospital screening for 
depression and anxiety as well as thoughts of self-harm identified less patients at risk, 




Implications: This study contributes to the nursing profession by highlighting the 
prevalence of PMADs, impact on families, ongoing barriers to identification and 
treatment, and highlights gaps in the existing hospital screening process as compared to 
screening utilizing valid, reliable instruments and provides the basis for implementing 





















This dissertation is dedicated to several people who were especially supportive 
and made completing this program possible.  Bret Caslavka, has helped me to stay 
focused on the end goal the past three years and never hesitates to perk me up by telling 
me how proud he is of me.  My parents, Dave and Hisae Reichel, and my brother, John 
Reichel, have always been my biggest fans when it comes to educational pursuits.  My 
kids Hayley, David, Katie, Lindsey and granddaughters Eleanor and Teagan have been a 

















I have a tremendous amount of gratitude for my Chair, Dr. Cynthia Connelly, for 
her witty guidance for the past three years.  Dr. Connelly’s expertise is invaluable, and I 
have learned so much from her.  Her confidence in me was tremendously helpful during 
those times when I was especially stressed. Special thanks go to Dr. Ruth Bush, who was 
not only a key member of my committee helping me make sense of my data, but also for 
her patience in teaching statistics to all the nursing PhD students.  Dr. Semira Semino-
Asaro has provided me with great insight and information in the field of women’s mental 
health and has been a wonderful role model. 
The faculty and staff in the Hahn School of Nursing and Health Science have 
been outstanding.  I would like to recognize Dean Jane Georges for her kind introduction 
to the program our first semester and for her ongoing leadership as the Dean.  Dr. Ann 
Mayo was instrumental in helping me to identify my research topic through our Concept 
Analysis assignment the first semester, and she continued to provide excellent feedback 
and guidance throughout the program.  Dr. Patricia Roth always made sure that we were 
taken care of and paid attention to the many details of the program.  
On the very first day of class I met two classmates who became good friends and 
helped me to stay focused and on track throughout the program. Nicole Pena Solares and 
Kimberly Sanchez were instrumental in my ability to finish this program in three years.  I 
feel very fortunate to know these impressive women and have had the benefit of their 






Table of Contents 
Chapter 1: Introduction ....................................................................................................... 1 
Background .......................................................................................................... 1 
Defining PMADs ............................................................................................. 1 
Factors ............................................................................................................. 2 
Significance.......................................................................................................... 4 
Study Purpose and Aims ...................................................................................... 5 
Conceptual Framework ........................................................................................ 6 
Chapter 2: Review of Literature ......................................................................................... 9 
Prevalence ....................................................................................................... 9 
Etiology and Risk Factors ............................................................................. 10 
Racial and Ethnic Factors .............................................................................. 14 
Adverse Outcomes ........................................................................................ 16 
Factors Affecting Identification and Treatment ................................................. 20 
Screening ....................................................................................................... 20 
Stigma ............................................................................................................ 24 
Social Support ............................................................................................... 26 
Summary ............................................................................................................ 27 
Chapter 3: Methodology ................................................................................................... 29 




Sample and Sampling Plan ............................................................................ 30 
Procedures .......................................................................................................... 31 
Recruitment and Enrollment Strategies ......................................................... 31 
Ethical Considerations ................................................................................... 32 
Variables and Operational Definitions............................................................... 32 
Demographic Variables ................................................................................. 33 
Depression ..................................................................................................... 33 
Anxiety .......................................................................................................... 34 
Stigma ............................................................................................................ 35 
Social Support ............................................................................................... 36 
Treatment Seeking Definition ....................................................................... 37 
Admission Screening Variables .................................................................... 37 
Data Analysis Plan ............................................................................................. 38 
Chapter IV: Results ........................................................................................................... 40 
Participants .................................................................................................... 40 
Summary ............................................................................................................ 50 
Chapter V: Discussion of Findings ................................................................................... 51 
Study Summary .................................................................................................. 51 
Nursing Implications .......................................................................................... 54 




Education ....................................................................................................... 55 
Limitations ..................................................................................................... 55 
Conclusion ......................................................................................................... 57 






List of Tables 
 
Table 1. Variables and operational definitions ..................................................................37 
Table 2.  Demographics .....................................................................................................42 
Table 3. Means and Standard Deviations ..........................................................................44 
Table 4. Correlations for Demographic Variables .............................................................46 
Table 5. Correlations for Study Variables .........................................................................46 
Table 6. Treatment-Seeking Follow-up .............................................................................48 
 
List of Figures 
Figure 1. Research Conceptual Framework .........................................................................8 
 
List of Appendices 
 
Appendix A: Study Flyer ...................................................................................................71 
Appendix B: Informed Consent .........................................................................................72 









 Perinatal mood and anxiety disorders (PMADs) constitute a global public health problem 
affecting 10% of pregnant women and 13% of postpartum women worldwide (Mental Health, 
n.d.).  Although data are limited for low- and middle-income countries, rates have been reported 
to be 2 to 3 times higher in countries with limited resources (United National Population Fund 
[UNFPA], 2007).  Prevalence in the United States is as high as 21% of childbearing women, yet 
these disorders are identified and treated less than half the time (Wisner et al., 2013, Yawn et al., 
2012).  With approximately 3.9 million women between the ages of 12 and 50 giving birth in the 
United States each year, this equates to nearly 81,900 diagnosed with a PMAD and up to 41,000 
left untreated (Facts for Features, 2017). There is a significant financial impact to society when 
mothers suffer from PMADs.  Using a pathway or decision modeling approach, Bauer, Knapp, 
and Parsonage (2016) estimated the lifetime costs of depression and anxiety in the perinatal 
period at 8,500 pounds per woman, 6.6 billion pounds annually in the United Kingdom, which is 
equivalent to more than 8 billion United States dollars per year.  
Background 
Defining PMADs 
Psychiatric disorders occurring during pregnancy and up to one year postpartum included 
under the term PMADs are depression, anxiety, obsessive-compulsive disorder, post-traumatic 
stress disorder, and psychosis (Gavin et al., 2005). Postpartum “blues” or “baby blues” are 
experienced by as many as 70% of new mothers and may include symptoms such as crying, 
irritability, and anxiety.  Symptoms of postpartum blues generally last only one to two weeks and 





than several weeks may be attributable to PMADs (Langan & Goodbred, 2016; O'Hara & 
Wisner, 2014; Schetter & Tanner, 2012).        
Factors 
The prevalence of PMADs vary in the literature with rates as high as 23%, yet only 16% 
of those who screen positive receive treatment (Byatt, Biebel, Friedman, Debordes-Jackson, & 
Ziedonis, 2013; Mayberry, Horowitz, & Declerq, 2007).  There are multiple factors contributing 
to the low rate of identification of mothers with PMADs. One factor is inadequate screening.  
Several valid, reliable screening instruments are available including the Edinburgh Postnatal 
Depression Scale (EPDS) which is available in multiple languages (Cox, Holden & Sagovsky, 
1987). Anxiety and depression may exist as comorbid conditions; however, the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) does not have a distinct diagnosis 
for perinatal anxiety, and symptoms of anxiety may be labeled as depression (American 
Psychiatric Association, 2013).  The use of additional screening instruments for anxiety have 
been explored including the Edinburgh Postpartum Depression Scale -3A (Swalm et al., 2010) 
and the Generalized Anxiety Disorder (GAD-7) (Spitzer, Kroenke, Williams, & Lowe, 2006), a 
7-item scale specifically designed to measure anxiety symptoms. Screening for PMADs at least 
once during the perinatal period using a standardized, validated instrument was recommended by 
the American College of Obstetricians and Gynecologists (ACOG, 2015.) This opinion was 
updated in November 2018 to include a recommendation that obstetric care providers not only 
screen, but also complete a full assessment of the patient’s mood and emotional well-being at the 
postpartum visit (ACOG, 2018). A 2019 policy statement from the American Academy of 





Yogman, Mattson & Rafferty, 2019). Screening may not be consistently completed, and if it is 
completed using clinical judgment rather than with a standardized, validated instrument, health 
care providers may not recognize symptoms (ACOG, 2018; Goodman & Tyler-Viola, 2010).   
Stigma is a factor contributing to the low rate of identification of mothers with PMADs. 
Stigma, or avoiding the label of mental illness, is one reason people choose not to pursue 
treatment for mental health (Corrigan, 2004; Corrigan, Watson, Warpinski, & Gracia, 2004). 
Dimensions of stigma have been described as internal/self, external/public, and disclosure 
stigma, which may affect treatment-seeking behavior in different ways (Corrigan, 2004; Moore, 
Ayers, & Drey, 2017). Internal stigma is when individuals attach stigma to their own identity. 
External stigma is the stigma held by the general public. Disclosure stigma is the stigma 
associated with disclosing symptoms and the expected discrimination associated with disclosure 
(Moore et al., 2017).  One aspect of stigma unique to the perinatal period is the external stigma 
of being viewed as a bad mother and the internalization of that stigma (internal/self-stigma). 
Depression can create a sense of failure and guilt further inhibiting mothers from disclosing 
symptoms (Abrams & Curran, 2011).  
While stigma may inhibit women from seeking treatment, social support may be a 
positive mitigating factor. Higher levels of perceived stress are associated with increased risk of 
depressive and anxiety symptoms, and higher perceived social support is associated with a 
decreased risk for depressive symptoms. Interventions to increase social support may help to 
improve maternal mental health (Schwab-Reese, Schafer & Ashida, 2017).  Informal social 
support from family and friends is associated with increased parental self-efficacy and decreased 






In addition to affecting large groups of women, untreated PMADs affect the entire 
family.  Mothers may have difficulty concentrating and functioning, may feel hopeless or 
anxious, may have sleep disturbances, may see changes in appetite and weight, and may become 
suicidal (Miller, 2002; Schetter & Tanner, 2012). Mothers with PMADs face increased risks of 
social isolation as a result of feelings of hopelessness (Letourneau et al., 2012).  Women 
experiencing postpartum psychosis have more severe mood disturbances, fluctuating between 
mania and depression, and may experience delusions and hallucinations.  The onset of 
postpartum psychosis is often sudden, occurring in the first few weeks after delivery (Doucet, 
Dennis, Letourneau, & Blackmore, 2009). Postpartum psychosis is less prevalent than perinatal 
depression and anxiety, occurring in one to two cases for every 1,000 births (Munk-Olsen, 
Laursen, Pedersen, Mors, & Mortensen, 2006). 
Expectant and new fathers have an increased risk of depression; approximately 10% of 
fathers experience depression during the postpartum period with the highest rates in the three to 
six-month period.  There is also an association between maternal and paternal depression 
(Paulson & Bazemore, 2010).  Infants and children of depressed parents are affected by PMADs. 
Pregnancy-related anxiety is associated with negative birth outcomes including preterm birth, 
which, in turn, increases the risk of infant mortality and can affect fetal neurodevelopment 
(Doktorchik et al., 2017; Kramer et al., 2009; Schetter & Tanner, 2012).  Parenting practices may 
be adversely affected by PMADs; depressive symptoms in parents may be negatively associated 
with positive interactions among parents and infants (Paulson, Dauber & Lieferman, 2006).  





al., 2016). The effects of parental depression can last into young adulthood with a higher risk of 
depression at age 18 when parents were depressed during the postpartum period (Gutierrez-
Galve et al., 2018). 
Qualitative research has identified stigma as a common barrier to treatment-seeking for 
women with postpartum depression (Byatt et al., 2013).  There is evidence in the literature 
supporting the inverse relationship between social support and depressive symptoms; however, 
there is a gap in the literature regarding the relationships between PMADs, stigma, and social 
support among postpartum women.   
Study Purpose and Aims 
The purpose of this descriptive, correlational, cross-sectional study was to examine the 
relationships among PMAD symptomatology, select demographics, stigma of mental illness, and 
levels of social support, among inpatient postpartum women.   
Research Question 1: Is there a relationship between stigma and PMAD 
symptomatology? 
Research Question 2:  Are there differences in the type of stigma (external, internal, and 
disclosure) and PMAD symptomatology, social support, and demographic factors such as age, 
race/ethnicity, and pregnancy intent? 
Research Question 3: What percentage of participants with PMAD symptomatology seek 
treatment after discharge?  
Research Question 4: What is the level of agreement between the current admission 
screen and the interview screen using the EPDS and GAD-7?  





Aim 1. Characterize a sample of inpatient postpartum women participating in mother-infant dyad 
care. 
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support, and 
select demographics within a sample of inpatient postpartum women. 
Aim 3. Assess treatment-seeking in women with PMAD symptomatology after discharge from 
the hospital.   
Conceptual Framework 
Known risk factors for PMADs include a previous history of depression or anxiety and 
sociodemographic factors, such as low income and unemployment; nonetheless, further study is 
needed to identify if racial and ethnic factors play a role in the prevalence of PMAD separately 
from socioeconomic factors (Liu & Tronick, 2013; Mayberry et al., 2007).  When a mother 
experiences a PMAD whether she has depression, anxiety, obsessive-compulsive disorder, post-
traumatic stress disorder or a combination thereof, stigma can create a barrier to identification 
and treatment. Stigma can be internal/self-stigma, external/public stigma, disclosure stigma, or a 
combination of the categories (Corrigan, 2004).   Erving Goffman’s (1963) concepts of stigma, 
Patrick Corrigan’s (2004) concepts of public stigma and self-stigma, and Moore and colleagues’ 
(2017) concepts of internal, external, and disclosure stigma will provide underpinnings for this 
research.  In addition, the work of Zimet, Dahlem, Simet, and Farley (1988) in developing the 
Multidimensional Scale of Perceived Social Support Scale (MSPSS) will provide the basis for 
examining the role of social support in potentially mitigating the stigma of mental illness.  High 
levels of social support are inversely correlated with depressive symptoms and may help to 





The inverse relationship between high levels of social support on depressive symptoms has been 
documented in the literature; however, there is a gap in the literature regarding the relationships 
among PMADs, stigma, and social support.  This study will help to clarify these relationships 
and the decision to seek treatment in a diverse sample of postpartum women (See Figure 1).  
Understanding the inter-relationships among these variables will facilitate understanding of how 
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Review of Literature 
Prevalence 
The prevalence of PMADs vary in the literature as a result of differences in the timing of 
screening, instrument used, and cut point selected to classify depressive disorders. A large, 
national cross-sectional study was conducted to review the differences in rates and severity of 
depressive symptoms in four postpartum cohorts (0-6 months, 7-12 months, 13-18 months, and 
19-24 months) using the EPDS.  Mild depression ranged from 11%-15.1%, with no statistically 
significant difference across the cohorts.  Moderate to severe depression ranged from 17.1-23.1% 
(Mayberry et al., 2007).       
A 2013 period prevalence study of 10,000 postpartum women was conducted to examine 
the timing of onset, prevalence, intensity of self-harm ideation, and specific primary and 
secondary PMAD disorders.  Mothers were screened during the hospital stay using the EPDS, 
and home visits were completed for 826 women with a score of 10 or higher on the EPDS for a 
diagnostic assessment.  Depression was identified in 21.9% of participants in the first year 
postpartum; 66.1% of patients diagnosed with PMADs had a comorbid diagnosis of depression 
and anxiety and 5.6% had a primary diagnosis of anxiety disorder.  Bipolar disorder was 
diagnosed in 22.6% of patients with depressive symptoms, which is significant because patients 
with bipolar disorder may be misdiagnosed with unipolar depression and improperly treated 
(Wisner et al., 2013). Strengths of this study include the large, heterogeneous sample, psychiatric 
diagnosis through home visits, analysis of the onset of symptoms, and the breakdown of 
psychiatric diagnoses.  Prevalence was not obtained for women with postpartum psychosis in this 




cases per 1,000 births and is generally seen in the first couple of weeks after delivery, coinciding 
with hormonal changes. Women with a history of bipolar disorder or a family history of bipolar 
disorder are at increased risk for developing postpartum psychosis (Sit, Rothschild, & Wisner, 
2006).  
Etiology and Risk Factors 
The etiology of PMADs is multi-faceted and not well-understood.  Genetic, biological, 
and environmental factors have been associated with PMADs. In a review of 17,912 phenotype 
records aggregated from a 19-country psychiatry consortium, latent class analyses were applied 
with two tiers: tier one assessed heterogeneity in subjects with data from the EPDS and tier two 
consisted of cases with postpartum depression.  There were 6,556 cases in tier one and 4,245 in 
tier two.  Three classes were established for both tiers with class 1 having the least severe 
symptoms (mean EPDS score 10.5), class 2 (mean EPDS score 14.8), and class 3 (mean EPDS 
score 20.1). It was determined that postpartum depression appears to have several clear 
phenotypes. In addition, increased rates of history of anxiety and mood disorders were found in 
the class 3 group, those with the most severe symptoms, supporting previous research on the 
strength of previous history as a risk factor for PMADs (PACT Consortium, 2015). Corwin, 
Kohen, Jarrett, and Stafford (2010) reviewed the genetic components of postpartum depression 
and concluded that although genetic polymorphisms may be linked to an increased risk of 
postpartum depression, the genes associated with PMADs would need to be identified, as well as 
the interactions between these genes, in order to identify a genetic risk profile.   
Biological models focus on the rise of reproductive and stress hormones in pregnancy 
and the abrupt decrease at delivery, triggering depressive symptoms in women with a genetic or 




of 16 healthy 22-45-year-old women with regular menstrual cycles who were at least one year 
past any recent childbirth, Bloch et al. (2000) divided the women into two groups.  One group 
had a history of postpartum depression without a history of nonpuerperal depression.  The 
second group had no history of current or previous mental illness.  In the baseline phase, 
participants received injections of a gonadotropin-releasing hormone analog to create a 
hypogonadal condition.  In the addback phase, hormones were added back and in the withdrawal 
phase, medications were replaced with placebo, which induced a dramatic drop in reproductive 
hormone levels.  Subjects received psychometric assessment during the study.  Analysis of 
variance with repeated measures indicated that there were significant differences in phases and 
groups.  Participants with a history of postpartum depression had a significant increase in 
symptom severity during the withdrawal phase with a mean score 6.3+3.8 on the EPDS as 
compared to 0.3+0.5 for the low risk group (p<.01), indicating a differential response to the 
abrupt decrease in hormones in women participants with a history of postpartum depression.  
This study established the existence of a hormone-sensitive phenotype for postpartum 
depression.  
Psychological models studying the etiology of PMADs focus on socioeconomic factors, 
stressors, and interpersonal relationships.  Factors such as age, education level, employment 
status, income, and parity have been associated with increased risk for PMADs. A cross-
sectional screening study of 1,359 postpartum women using the EPDS was conducted to examine 
the differences in depressive symptoms and associated factors.  The highest depression rates 
were found in the youngest age group (18-24 years): 16.4% for mild depression and 29.9% for 
moderate to severe depression.  Participants in the lowest income bracket had the highest 




moderate to severe depression. Lower education levels, higher parity, and unemployment were 
positively correlated with depression rates.  A multivariate analysis indicated income, age, 
education, and parity were independently correlated with a score of 13 or higher on the EPDS, 
indicating moderate-to-severe depression symptoms (Mayberry et al., 2007).   
A key risk factor for perinatal depression and anxiety is a previous history of depression 
or anxiety.  In a prospective cohort study of pregnancy outcomes and maternal and child health, 
1,662 women completed a questionnaire eliciting history of depression and EPDS scores during 
pregnancy and 6 months postpartum.  The greatest risk factor for antepartum depression was a 
history of depression (OR=4.07, 95% CI: 3.76, 4.40). The greatest risk factor for postpartum 
depression was depressive symptoms during pregnancy (OR= 6.78, 95% CI: 4.07, 11.31) or a 
history of depression prior to pregnancy (Rich-Edwards et al., 2006).  Similar findings were 
found in a meta-analysis of 57 studies in which the greatest risk factor identified was a history of 
depression (Langan & Goodbred, 2016).   
Unintentional pregnancy has been identified as a risk factor for PMADs. In a prospective 
cohort study, 2,128 women were screened for depressive symptoms using the EPDS during 
pregnancy, and 1,278 of the participants completed the EPDS at 6 months postpartum.  
Demographic information was collected via interview and survey.  A cutoff score of 12 was used 
to identify probable depression.  A total of 9% of antepartum patients scored >12 on the EPDS 
(n=155), and 8% (n=101) scored >12 in the postpartum period.  This study modeled 
sociodemographic predictors of depressive symptoms in the antepartum and postpartum periods.  
Findings included a more than two-fold increase in association between unintended pregnancy 
and risk for depressive symptoms during pregnancy (OR=2.31 95% CI: 1.29, 4.16). When the 




depression, a weaker association was identified (OR=1.89, 95% CI: .85, 4.20) indicating the 
influence of a history of depression.  Because there was an increased risk for depression in 
participants with unintended pregnancy and no history, unintended pregnancy may be an 
independent risk factor (Rich-Edwards et al., 2006).  In a review of data from the National 
Survey of Family Growth (NSFG), Finer and Zolna (2016) analyzed rates of unintended 
pregnancy from 2008 to 2011. Of the 6.1 million pregnancies in the United States in 2011, 45% 
(2.8 million) were unintended.  An inverse relationship was identified among income and 
educational level and unintended pregnancy.  This study did not examine relationships between 
unintended pregnancy and PMAD.  
A cross-sectional study of 8,916 mothers was conducted to review the public health 
impact of depression, prevalence, sociodemographic, and other factors.  Utilizing data from the 
National Epidemiological Survey of Alcohol and Related Conditions, findings indicated 
depression was highly associated with socioeconomic factors, and depressed mothers faced more 
challenges, for instance, unemployment, poverty, single parenting, and financial difficulties.  
Young mothers, those with low education or income levels, unemployed, or divorced or 
separated, had higher rates of depression.  Models predicting depression indicated higher rates of 
depression related to age 18-24 (OR=1.38, 95% CI: 1.02, 1.85), education less than high school 
(OR=1.65, 95% CI: 1.16, 2.36), lowest quartile income <$20,000 (OR=1.53, 95% CI: 1.09, 
2.15), unemployed (OR=3.27, 95% CI: 2.50, 4.28), and divorced or separated (OR=1.87, 95% 
CI: 1.47, 2.39) (Ertel, Rich-Edwards, & Koenen, 2011).  
Mothers of preterm and critically ill infants are at increased risk for depression and 
anxiety.  In a study that was a subset of a prospective, longitudinal study of 69 mothers and their 




psychological distress and psychological history were recorded along with demographic 
information and infant outcome variables. Questionnaires were administered at two time 
intervals: T1–two to four weeks after delivery and T2–a mean interval of 14.8 days prior to 
discharge. From T1 to T2, 65.5% of participants met criteria for at least one domain of distress 
such as depressive symptoms, anxiety, or post-traumatic stress. Multiple regression analysis 
indicated that being single and/or being in a relationship but not living together were associated 
with higher depressive symptomatology at T1 (Greene et al., 2015). 
 The increased depression and anxiety risk was demonstrated in a cohort study in 
Hamburg, Germany of 230 families, 111 with very low birthweight infants (VLBW) and 119 
with term infants.  The families were prospectively followed and were administered the EPDS, 
Beck Depression Inventory (BDI) and structured clinical interview.  With a reference of EPDS 
>13, parents with VLBW infants had a 5.1 times higher risk for postpartum depression than term 
infants (OR=5.1, 95% CI: 2.24, 11.80) (Helle et al., 2015).  Similarly, a cohort of 73 mothers of 
preterm infants was administered the EPDS and the State-Trait Anxiety Inventory (STAI); 20% 
of mothers had depressive symptoms and 43% had moderate to severe anxiety (Rogers, 
Kidokoro, Wallendorf, & Inder, 2013). 
Racial and Ethnic Factors 
Risk factors for PMADs have been well-studied, however the variation in prevalence by 
race and ethnicity is unclear.  Liu and Tronick (2013) reviewed birth certificate data and data 
from the New York City (NYC) Pregnancy Risk Assessment Monitoring System (PRAMS), a 
population-based survey of postpartum women.  The goal of PRAMS was to monitor behavior 
and experiences of mothers in the antepartum, intrapartum, and postpartum periods.  A random 




several questions related to depression and questions about income, stressful events during 
pregnancy, whether the pregnancy was planned, and level of social support.  The outcome 
variable for the study was a diagnosis of depression.  Information about race, ethnicity, and 
country of origin was obtained from birth certificate data. This study found Asian/Pacific 
Islander women had the highest postpartum depression rates followed by Hispanics and African 
Americans; however, after adjusting for sociodemographic factors, these differences were either 
less pronounced or eliminated. A finding in this study was that African Americans and Hispanics 
with lower socioeconomic status were less likely to be diagnosed than White and Asian 
participants, indicating that further study is needed regarding the process of diagnosing women 
in lower socioeconomic groups.  
In a review of an ongoing longitudinal study of a diverse group of women receiving 
prenatal care at a university-based hospital clinic in Washington state, 1,997 women completed 
at least one questionnaire at a clinic visit related to depression and anxiety using the Patient 
Health Questionnaire short form (PHQ-15) (Kroenke, Spitzer & Williams, 2002).  The PHQ-15 
measures 15 physical symptoms related to mental disorders, health behaviors, sociodemographic 
factors, and psychosocial factors.  The objective was to examine racial and ethnic differences in 
the prevalence of prenatal depression in a community-based sample of pregnant women. In this 
sample, 5.1% reported depression with the highest rates in Blacks and Asian/Pacific Islanders as 
compared to non-Hispanic White women. Study findings included African American women 
(AOR=2.93, 95% CI: 1.38, 6.18) and Asian/Pacific Islander women (AOR=2.14, 95% CI: 1.02, 
4.52) had higher odds of antepartum depression after controlling for sociodemographic, 




differences related to PMAD is needed to clarify factors associated with differences in 
depression prevalence.  
Adverse Outcomes  
PMADs affect mothers, fathers, infants, children, and ultimately, society.  Mothers with 
PMADs may have depressed mood, anhedonia, appetite and weight changes, sleep disturbances, 
agitation, fatigue, difficulty concentrating, and suicidal ideation (American Psychiatric 
Association [APA], 2013).  Women experiencing postpartum psychosis, a less common and 
more severe mental illness, occurring in 1-2 cases for every 1,000 deliveries, have more severe 
mood disturbances, fluctuating between mania and depression, and experience delusions and 
hallucinations (Doucet et al., 2009).  Suicide is one of the leading causes of death in the perinatal 
period (Palladino, Singh, Campbell, Flynn, & Gold, 2011).  
Fathers are at increased risk for depression in the perinatal period, which may be 
explained in part by maternal depression.  In a meta-analysis of 43 studies that documented 
depression in fathers between the first trimester of their partner’s pregnancy and the first year 
postpartum, 10% of fathers experienced prenatal and postpartum depression with the highest 
rates at the three to six-month postpartum period. Paternal depression was positively correlated 
with maternal depression (Paulson & Bazemore, 2010). Another aspect of paternal depression 
may be related to stress. Parents of babies admitted to neonatal intensive care (NICU) faced 
increased stress. In an observational, longitudinal design study, fathers of infants admitted to the 
NICU with an expected length of at least three weeks completed questionnaires at four time 
points: on admission through 2 weeks (T1), 3 weeks from admission (T2), at discharge (T3), and 
2 months after discharge (T4). The Parental Stress Scale (PSS) (Berry & Jones, 1995) was used 




period, 11.8% of fathers had high stress levels as defined by PSS>43, which decreased to 7.6% at 
discharge (T3) and increased to 12.6% at T4. A decrease in major symptoms of depression as 
defined by EPDS >13 was noted from 16.3% at T1, which decreased to 2% at T4. Although 
symptoms of depression decreased, depressive symptoms and high levels of stress persisted in 
some fathers across all measured time points. This study utilized a convenience sample and did 
not collect information about pre-existing stress or history of depression.  (Cyr-Alves, Macken, 
& Hyrkas, 2018).  
There are many ways in which PMADs affect infants and children including negative 
birth outcomes and parenting practices affecting their social and emotional development.  
Anxiety during pregnancy has been associated with preterm birth, the leading cause of infant 
mortality globally (World Health Organization, 2017).  A multicenter prospective cohort study of 
5,337 women who gave birth in Montreal, Canada over a period of five years was conducted to 
study stressors and measures of psychological distress.  Pregnancy-related anxiety was 
independently associated with increased spontaneous preterm birth after controlling for medical 
and obstetric risk (Kramer et al., 2009).  The All our Babies (AOB) cohort study in Calgary, 
Alberta, Canada included 3,388 pregnant women who completed questionnaires at 17-24 weeks 
and 34-36 weeks of pregnancy.  Anxiety was measured using the Speilberger State Anxiety 
Scale (Spielberger, 2010) and depression was measured using the EPDS.  Chronic stress was 
measured once at 17-24 weeks of pregnancy using the Perceived Stress Scale (PSS) (Cohen, 
Kamarck, & Mermelstein, 1983). Findings included that women with an increase in anxiety 
during pregnancy had higher odds of preterm birth as compared to the women who had 
decreased anxiety during pregnancy (OR=2.7, 95% CI 1.28, 5.69; p=.009). Women with 




significant relationship was not found between increased depression scores during pregnancy and 
preterm birth (Doktorchik et al., 2017). 
Anxiety in pregnancy has also been linked to adverse infant development and 
malnutrition.  A prospective cohort study of 160 infants of depressed mothers and 160 infants of 
mothers who were not depressed was conducted to examine the impact of maternal depression on 
infant malnutrition and illness.  Infants were weighed and measured at three different intervals in 
the first year and mothers’ mental status was reassessed at the same intervals.  The study found a 
significant relative risk of the infants being underweight (RR=4.0; 95% CI: 2.1-7.7) at 6 months 
of age and (RR= 2.6; 95% CI: 1.7-4.1) at 12 months of age when the mother was depressed.  The 
association between maternal depression and relative risk of underweight for infants was 
significant after adjusting for confounders such as birth weight and socioeconomic status 
(Rahman, Iqbal, Bunn, Lovel, & Harrington, 2004).   
The negative birth outcomes associated with PMADs may be mitigated through 
preventative programs. In a randomized control trial studying the preventive effects of a 
parenthood program, a sample of 399 couples was enrolled in a study if they were expecting 
their first baby, were cohabitating or married, and were at least 18 years old.  The couples were 
randomly assigned to an intervention or control group.  The intervention group attended nine 
classes on a number of skills including communication and conflict resolution. Stress and mental 
health status were measured via the Center for Epidemiological Scale (CES-D) (Radloff, 1977), 
and the State-Trait Anxiety Inventory (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983).  
After delivery, data were collected on birth weight and birth date. One of the study findings was 
the intervention appeared to buffer against the negative effects of financial stress, anxiety, and 




Parenting practices can be adversely affected by PMADs. In a review of data from the 
Early Childhood Longitudinal Study of 5,089 two-parent families, depressive symptoms were 
assessed using a short form of the Center for Epidemiological Studies Depression Scale (CESD) 
(Radloff, 1977).  Interviews provided information on interactions among parents and infants.  
Depression was identified in 14% of mothers and 10% of fathers and depressive symptoms were 
negatively associated with positive interactions among parents and infants.  When parents were 
depressed, they spent less time reading or telling stories to their infants (Paulson et al., 2006). 
Maternal depression can affect children’s social and emotional development. In a 
longitudinal cohort study of 3,752 women in Oslo, Norway, study participants were given the 
EPDS during pregnancy, at 8 weeks postpartum, and 2 years after delivery. Emotional 
development in the children was assessed using the Ages and Stages Questionnaire: Social-
Emotional (ASQ:SE) (Squires, Bricker, & Twombly, 2002) as well as parent questionnaires 
about the children’s behavior. Depressive symptoms during pregnancy or during the postpartum 
period were independently associated with social and emotional problems in children as 
compared to the children of mothers who were not depressed.  The Adjusted Odds Ratio for 
children’s social and emotional problems 2 years after birth (adjusted for social support, current, 
and perinatal depression), was 3.4; 95% CI 1.4-8.0, p=.01 during pregnancy, 3.8; 95% CI 1.7-
8.6, p=.01 at 8 weeks postpartum, and 3.7; 95% CI 1.3-10.1, p=.01 at both occasions (Junge et 
al., 2016). 
Parental depression can have lasting effects on children. A prospective longitudinal 
cohort study of 3,176 father and child pairs in the United Kingdom found that children of fathers 
who were depressed during the postpartum period had an increased risk of depression at age 18 




CI .02-.09, p=.004. The authors state this was explained by the indirect associations of maternal 
depression at 8 months postpartum (Gutierrez-Galve et al., 2018). 
Factors Affecting Identification and Treatment 
Screening  
One of the factors contributing to the low rate of identification of women with PMADs is 
a lack of consistent screening.  Screening for depression at least once during the perinatal period 
for depression and anxiety symptoms utilizing a standardized validated instrument is 
recommended by the American College of Obstetricians and Gynecologists (ACOG).  The 
Committee Opinion Number 630 previously published in 2015 was updated in November 2018 
as Committee Opinion Number 757 to add that a full assessment of a patient’s mood and 
emotional well-being be conducted for each patient (ACOG, 2018). 
The American Academy of Pediatrics (AAP) published a report in 2010 recommending 
screening for perinatal depression in pediatric primary care at one, two, four, and six month well-
baby visits (Earls, 2010). Pediatricians are in a unique position to help identify PMADs since 
mothers typically have regular contact with pediatric care providers in the first year of a baby’s 
life.  A 2013 survey of AAP members indicated that less than half of pediatricians were 
screening mothers. A 2019 AAP policy statement reinforced the recommendation that screening 
be included in well-child visits and recommended that pediatricians be provided with training 
and continuing medical education programs regarding perinatal screening and referral (Earls et 
al., 2019). 
A literature review of articles published between 2003 and 2013 regarding physician 
attitudes towards perinatal depression screening included 11 research studies in the United 




practitioners were reviewed. Screening was perceived to be the role of 75%-90% of physicians; 
however, 55% reported that they never, sometimes, often, or always completed screening.  
Clinical judgment was the most common screening method; a screening tool was used by 7% of 
pediatricians and 36% of obstetricians. (Evans, Phillippi, & Gee, 2015).  
The feasibility of screening was demonstrated in a prospective cohort study in a 
Midwestern urban pediatric outpatient clinic.  New mothers were routinely screened for PMADs 
at their 2-month and 4-month well-child visit using the EPDS, and a 6-month screening was 
added.  In addition to the EPDS, a survey was administered regarding the feasibility of adding a 
6-month screening.  At the 6-month point, 43 participants were screened; six had scores >10 
indicating that they were at risk and of these six, two had not previously been identified.  The 
survey indicated more than half of the respondents agreed the additional screening would not be 
a waste of time (Emerson, Matthews, & Struwe, 2018).  This study not only included a small 
sample, it also reviewed the feasibility of adding additional screening to a practice that already 
had screening in place at well-child visits and may not be representative for pediatric practices 
which have not yet implemented screening.   
While screening in pediatric practices may be feasible, it may not occur consistently.  In a 
descriptive, cross-sectional design study, more than 80% of the 98 pediatric physicians and 
advanced practice nurses surveyed agreed they were responsible for recognizing maternal 
depression, yet only 7% used a screening questionnaire.  Barriers to screening included 
inadequate time, medical problems of the child being more pressing, mothers reluctant to accept 
diagnosis, and incomplete knowledge of providers to diagnose or counsel (Connelly, Baker, 




The gap in screening for PMADs was demonstrated in a study conducted in a large, urban 
teaching hospital in Boston, Massachusetts.  A convenience sample of 491 women was screened 
using the EPDS and the anxiety components of the Patient Health Questionnaire (PHQ) (Spitzer, 
Kroenke & Williams, 1999) during the third trimester of pregnancy and again at 6 weeks after 
delivery.  The questionnaire mailed to participants at 6 weeks postpartum included additional 
questions about stress and use of psychotropic medications.  These data were correlated with 
information from medical records regarding psychiatric symptoms, diagnoses, treatments, and 
referrals to psychiatric services.  Of the participants, 113 women (23%) screened positive for 
anxiety or depressive symptoms prenatally but only 46 (41%) of these participants’ medical 
records included documentation of symptoms or diagnoses. Of these 46 women, only 17 (37%) 
had documentation of mental health treatment.  In the postpartum portion of the study, 299 
women (61%) completed the questionnaire and 51 (17%) screened positive for anxiety or 
depressive symptoms.  Of these 51 women, 15 (29.4%) had documentation of symptoms or 
diagnoses in the medical record, and 13 (87%) had documentation of mental health treatment. By 
comparing anxiety and depression symptoms in the antepartum and postpartum periods with 
medical record documentation, this study identified a gap between self-reported symptoms and 
identification of PMADs (Goodman & Tyler-Viola, 2010).  
Patients may not be averse to being screened. In a mail survey of 168 women in the first 
year postpartum, Walker, Murphey, and Xie (2016) reviewed discussions between patients and 
providers on topics such as behavioral and psychological health and acceptability of mental 
health screening. Just over 48% of participants indicated that behavior or psychosocial health 
topics were not discussed in any health care visits during the year after giving birth.  More than 




a computer or tablet at a women’s health visit.  The majority of participants (92%) indicated they 
were comfortable answering similar questions during a pediatric health visit.  
If screening is completed only once during the perinatal period or at a time when 
symptoms are not present, patients at risk may be missed. The objective of a retrospective cohort 
study in Camden, New Jersey was to determine if screening once using the EPDS is enough and 
whether screening once within 96 hours after delivery is predictive of a later EPDS score done at 
the outpatient postpartum visit.  The majority of studies utilizing the EPDS have been conducted 
in the outpatient setting.  This study screened patients in the hospital using the EPDS and again 
at 2 and 8 weeks postpartum as per usual practice.  Further evaluation was conducted for EPDS 
scores >10 or for suicidal ideation. Inpatient EPDS scores were compared with outpatient EPDS 
scores for 256 participants and three groups were identified based on EPDS scores.  The low risk 
group had EPDS scores <10, borderline risk was 10-13, and high risk was >14. The final sample 
size was 205 after cases were excluded such as when two EPDS scores were not available or if 
they were completed outside the study interval. Delivery and outpatient records were reviewed. 
The majority of participants (92%) fell in the low risk group, 5.4% were in the borderline group, 
and 2.4% were in the high-risk group.  In comparing EPDS scores between the three time periods 
(inpatient, first outpatient, second outpatient), low risk participants had a 92.7% probability of 
continuing to be low risk. Participants with worsening EPDS scores had a significant difference 
in previous history of mental illness (p=.003) and fetal anomaly (p=.05) as compared to those 
whose EPDS scores were unchanged or improved (Knights, Salvatore, Simpkins, Hunter & 
Khandelwal, 2016).  This study supports the need to screen women more than once during the 
perinatal period, and screening during the hospital stay by nurses may be an effective way to 





A significant factor contributing to the low rate of identification of women with PMADs 
is stigma.  The Surgeon General’s 1999 report found in addition to stigma impacting a person’s 
acknowledgement of a mental illness, stigma also affects seeking treatment and staying in 
treatment (Office of the Surgeon General, 1999).  Avoiding the label of mental illness is one 
reason why people choose not to pursue treatment for mental health (Corrigan, 2004).  Erving 
Goffman (1963) in his seminal work described stigma as a discrediting attribute that makes a 
person different from others, reducing the person in our minds to someone who is tainted and 
discounted.  Goffman’s conceptualization of stigma is that it effectively inhibits an individual 
from being fully accepted by society.   
Building on Goffman’s work, Corrigan (2004) described stigma as an experience of two 
interdependent concepts: public stigma and self-stigma. Public stigma is the stigma directed by 
the general population and self-stigma is the internalization of these thoughts, beliefs, behaviors, 
attitudes, and stereotypes associated with a particular group.  Moore et al. (2017) measured three 
aspects of stigma in the development of the City Mental Illness Stigma Scale (City MISS) 
(Moore et al., 2017): internal stigma, perceived external stigma, and disclosure stigma.  A 
convenience sample of 279 women, recruited via PMAD-related websites and social media, 
completed the City MISS and Internalized Stigma of Mental Illness Scale (ISMI) (Boyd, 
Otilingam, & Grajales, 2003).  The internal stigma subscale was developed to describe the 
association between internal stigma and a mother’s feelings of inadequacy.  The external stigma 
subscale measures the stigma a mother perceives others think about mothers with mental health 
issues.  The disclosure stigma subscale measures the expected discrimination if symptoms were 




Cronbach’s alphas of .84, .81, .86, and .85 respectively. The City MISS is the first instrument 
designed to measure the stigma experienced by women with PMADs.  
Disclosure is an aspect of stigma that may inhibit women from being identified and 
treated. Dennis and Chung-Lee (2006) found in a qualitative, systematic review, a common 
barrier to help-seeking was an inability to disclose symptoms further hindered by social 
pressures and the label of mental illness.  Disclosure stigma may be related to treatment-
avoidance and in some cases pertains to a fear of having to discontinue breastfeeding.  Mothers 
may avoid treatment as a result of potential contraindication between breastfeeding and 
psychotropic medications.  A convenience sample of 509 pregnant women, in the last trimester 
of pregnancy, completed a questionnaire regarding treatment modalities for depression, attitudes 
toward depression treatment, and perceived barriers. Ninety-two percent responded they would 
participate in therapy if they needed help. Only 35% stated they would take medication.  Most 
women reported they would not take psychotropic medication while pregnant (66%) or lactating 
(64%).  This study supports the concern mothers with PMADs face when wanting to continue to 
breastfeed their infants (Goodman, 2009).     
Continuing breastfeeding may be protective for depression and anxiety symptoms. In a 
prospective cohort study conducted in Norway, researchers studied the relationship among 
breastfeeding cessation, depression, and anxiety symptoms.  The cohort of 42,225 participants 
from the Norwegian Mother and Child Cohort Study was assessed at 17 weeks’ gestation, 30 
weeks’ gestation, and 6 months postpartum.  This study supported earlier findings that 
breastfeeding is associated with reduced depression and anxiety symptoms.  Women with 
prenatal anxiety and depression were more likely to have increased anxiety and depression after 




Literature exists regarding the prevalence of PMADs and the impact on the family; 
nonetheless, few quantitative studies were found reporting the relationship between PMADs and 
stigma.  In a descriptive study of 509 women in the last trimester of pregnancy, participants 
completed the EPDS, a questionnaire on treatment preferences for depression or anxiety, and a 
survey on barriers to obtaining professional help.  The top perceived barrier to obtaining help for 
depression or anxiety was time (64.7%), followed by stigma (42.5%) (Goodman, 2009).  The 
focus of this study was on treatment preferences and did not explore the relationships between 
stigma and PMADs in depth.  
Qualitative studies have identified several themes related to PMAD and stigma.  Stigma 
was a theme in the grounded theory focus group study conducted by Byatt et al. (2013) 
examining barriers to identifying postpartum depression in pediatric settings.  The theme was 
ambivalence about screening due to concerns about stigma and losing parental rights. Abrams 
and Curran (2011) interviewed low income mothers with infants 12 months or younger in the 
Women, Infant, and Children (WIC) federal nutrition program in two cities.  One of the central 
constructs identified was depression creates a sense of failure and mothers attached a “bad 
mother” stigma to themselves.  Not only is there the external stigma of being viewed as a bad 
mother, there is also the internalization of that stigma and a sense of failure and guilt.  Women in 
this population face the double stigma of depression and poverty.  
Social Support 
 While stigma may inhibit women from seeking treatment, social support may be a 
positive mitigating factor.  In a prospective cohort study, 222 postpartum women completed the 
EPDS, the Maternity Social Support Scale (MSSS) (Webster et al., 2000), and the World Health 




weeks after delivery. A cutoff >10 for the EPDS indicates probable depressive symptoms and in 
this study, 47 (21.8%) scored >10 on the EPDS. Women with a score >10 were contacted by 
telephone for further follow up.  The highest possible score for the MSSS is 30 with higher 
scores indicative of higher levels of social support.  Women with scores 0-24 on the MSSS had a 
mean score of 9.41 on the EPDS; in contrast, women with MSSS scores >24 had a mean score of 
6.74 on the EPDS indicating a statistically significant (p=.0007) inverse relationship between 
social support and depressive symptoms (Webster et al., 2011).  
A descriptive, correlational study was conducted to examine the relationships among 
social support, maternal parental self-efficacy, and depression in first-time mothers in a 
maternity unit in the Republic of Ireland.  Four hundred and ten mothers completed 
questionnaires at 6 weeks postpartum including the EPDS and the Perceived Maternal Parental 
Self-Efficacy Scale (Barnes & Adamson-Macedo, 2007), an instrument measuring functional 
social support and structural social support.  Family and friends were identified as the main 
source of social support (mean 4.94, SD 1.8).  The study identified a statistically significant 
correlation between social support and maternal prenatal self-efficacy (r=0.21, p<.001) and 
statistically significant negative correlations between social support and EPDS scores (p<.001).  
This study supports the association among informal social support (family and friends) and 
parental self-efficacy as well as the inverse relationship between social support and postpartum 
depression (Leahy-Warren et al., 2011).  
Summary 
 The etiology of PMADs is multifactorial and any approach to studying PMAD 
must incorporate quantification of several risk factors to include history of depression, young 




2016).  There are adverse outcomes affecting the entire family as a result of PMADs including 
sleep disturbances and suicidal ideation in mothers, pre-term birth and adverse development in 
infants, and depression in partners (Miller, 2002; Wisner, Parry, & Piontek, 2002). Screening and 
stigma are factors affecting the identification and treatment of women with PMAD; in contrast, 
social support can be a positive mitigating factor (Byatt et al., 2013; Goodman & Tyler-Viola, 
2010; Webster et al., 2011).  There is a gap in the literature regarding relationships among 







The purpose of this study was to examine the relationships among select patient 
characteristics, self-report of depressive symptoms, social support, and stigma of mental 
illness in inpatient postpartum women. This chapter provides the research methodology 
including study aims, research design, sample and sampling, instruments, data collection 
procedures, data analysis, and protection of human subjects.  
The research questions for this study include: 
Research Question 1: Is there a relationship between stigma and PMAD 
symptomatology? 
Research Question 2:  Are there differences in the type of stigma (external, 
internal, and disclosure) and PMAD symptomatology, social support, and demographic 
factors such as age, race/ethnicity, and pregnancy intent? 
Research Question 3: What percentage of participants with PMAD 
symptomatology seek treatment after discharge?  
Research Question 4: What is the level of agreement between the current 
admission screen and the interview screen using the EPDS and GAD-7?  
The research questions were addressed through the following aims: 
Aim 1. Characterize a cohort of inpatient postpartum women participating in mother-
infant dyad care. 
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support, 




Aim 3. Assess treatment-seeking in women with PMAD symptomatology after discharge 
from the hospital.   
Study Design 
A descriptive cross-sectional correlational design was used in this study.  The 
rationale for this study design is, although much is known about the prevalence of and 
risk factors for PMADs, the literature lacks consistency of findings related to the 
relationships among PMADs, stigma, and social support in postpartum women. This 
study will provide an opportunity to better understand the relationship among these 
variables in a diverse sample of postpartum women. 
Sample and Sampling Plan 
A purposive sample of inpatient postpartum mothers who gave birth between July 
2018 and August 2018 at a 208-bed free-standing women’s community hospital located 
in a large southern California metropolitan area was recruited and enrolled.  The patient 
population in this hospital is diverse with approximately 44% non-Hispanic White, 19% 
Hispanic, 10% Asian, 5% African American, 0.2% Native American, and approximately 
21% other.  Inclusion criteria: minimum of 24 hours post-delivery to ensure participants 
were adequately recovered from delivery with infants in dyad care and English or 
Spanish speaking.  Languages chosen were based on the availability of bilingual 
Research Assistants (RA). Exclusion criteria: mothers whose babies were in Neonatal 
Intensive Care or at the local children’s hospital. This exclusion was established because 
of the increased risk for depression and anxiety in mothers with preterm and very low 




Power Analysis.  The greater the variability in the population, the higher the risk 
a larger sample is needed to capture the full variation in the sample (Polit, 2010; Polit & 
Beck, 2012).  This study included nine independent variables to be tested within a 
bivariate logistic regression model.  There is no recognized power calculation for logistic 
regression but a general rule to ensure adequate cell size in the contingency tables is a 
minimum of 20 cases for each independent variable, or 180 mothers.  This was 
considered to be sufficient to detect a moderate standardized Effect Size (d = 0.32) using 
a two-tailed significance test with a power of .80 and a significance level of .05 (Cohen, 
1988; Polit & Beck, 2012).  
Procedures 
Recruitment and Enrollment Strategies 
Fliers recruiting patients for the study were distributed to postpartum nursing staff 
at shift huddles to introduce the study (Appendix A).  A brief explanation of the study 
was provided to nurses so they could answer basic questions about the study.  Each day 
of data collection, the Principal Investigator (PI) reviewed the list of potential patients 
and screened them for inclusion.  The PI or bilingual RA then invited them to participate, 
obtained informed consent (Appendix B), and provided subjects with the survey study 
packet including resources for follow-up and instruments for self-scoring after discharge.   
The survey packet was comprised of four de-identified standardized measures and 
a demographic survey including age, race/ethnicity, marital status, parity, pregnancy 
intent, language, type of delivery, and history of mental illness.  It was estimated the 
study instruments would take participants no more than 15 minutes to complete.  After 




pre-arranged time to collect the packets. If a participant responded positively to question 
#10 on the EPDS, “The thought of harming myself has occurred to me,” the participant 
was visited by a social worker to determine if further follow-up was needed.  Participants 
were given the option of providing their phone number for additional resources after 
discharge and those who scored 10 or higher on the EPDS or GAD-7 were contacted by 
the PI approximately one month after discharge to identify (or assess) if they obtained 
further evaluation and treatment. In acknowledgment of their time, a $10 gift card was 
provided to participants and a copy summary of the study results was made available to 
participants if they asked to receive one.  
Ethical Considerations 
The proposed investigation was reviewed and the Institutional Review Board 
(IRB) of the participating hospital and the University of San Diego provided study 
oversight. Informed consent was obtained through an introductory letter attached to the 
study instruments.  Participation in the study was voluntary.  Precautions were taken to 
protect patient privacy in accordance with the Health Insurance Portability and 
Accountability Act (HIPPA).  Subject-level data were recorded using only a study ID 
number and no personal identifying information. All study data were accessible only by 
the investigator. During the investigation period, all printed materials were kept in a 
secure, locked office, accessible only by the PI.  
Variables and Operational Definitions 






 Data were collected on potential covariates including age, race/ethnicity, primary 
language, marital status, parity, whether the pregnancy was planned or unplanned, type of 
delivery, and mental health history.  Although the correlations between race, ethnicity 
and PMADs may be more a result of sociodemographic factors, race/ethnicity and 
primary language were included in the demographic survey. Young age, lower education 
levels, single parenthood, high parity, unintended pregnancy, and mental health history 
are associated with an increased risk of PMADs; therefore, these factors were also 
included in the demographic survey. Age was measured in years. Race/ethnicity was 
measured by the following classifications: White, Black, Hispanic, Asian/Pacific 
Islander, and Multi-ethnic.  Primary language was measured as English, Spanish, or other 
(write in). Marital status was measured as married, single living with the father of the 
baby, and single not living with the father of the baby.  Parity was measured by the 
number of previous live births.  Intention for pregnancy was measured as yes for planned 
pregnancy, no for unplanned pregnancy. Although evidence regarding a relationship 
between type of delivery and risk for PMADs was not identified in the literature, type of 
delivery was included and was measured as vaginal, planned Cesarean section, or 
unplanned Cesarean section. Mental health history was measured as history of 
depression, anxiety, both depression and anxiety, other mental health diagnosis, or no 
history/no answer.  
Depression  
       Depressive symptomology was measured by the EPDS, a 10-question 




seven days.  Responses were scored on a scale from 0-3.  The scores were totaled and 
ranged from 0 to 30 with a higher score indicating greater depressive symptomatology.  
A score identification of possible depression and anxiety was based on a pre-determined 
cut-off score.  Cox and colleagues, who developed the EPDS, found a cut score of 12 or 
greater identified more than 80% of mothers with a major depressive disorder (Cox et al., 
1987).  A systematic review of validation studies identified the most commonly used cut-
off scores of 9-10 for possible depression, 12-13 and higher for probable depression 
(Gibson, Mc Kenzie-McHarg, Shakespeare, Price, & Gray, 2009).    
Reliability and validity studies by the developers of the EPDS identified 
sensitivity 86%, specificity 78%, and positive predictive value 73%.  The alpha reliability 
was .87 (Cox et al., 1987). The EPDS is publicly available and has been extensively 
validated across multiple community, culturally, and ethnically diverse populations and 
may be administered in Spanish or English (Alvardo-Esquivel, Sifuentes-Alvarez, Salas-
Martinez, & Martinez-Garcia, 2006).  The EPDS has been translated into many 
languages. In this sample the Cronbach alpha was α =.81. 
Anxiety  
Anxiety symptomatology was measured using the GAD-7 (Spitzer et al., 2006), a 
7-item screen, asking the participant to rate emotions over the previous two weeks on a 4-
point Likert scale.  Responses are scored on a scale of 0 to 3 and total possible scores 
ranged from 0-21 with higher scores indicating greater anxiety symptomatology. 
Reliability for the GAD-7 was established by the instrument developers with Cronbach’s 
alpha=.92 and test-retest reliability was 0.83.  Convergent validity with the Beck Anxiety 




established with scores of 0-4 associated with minimal anxiety, 5-9 mild anxiety, 10-14 
moderate anxiety, and 15-21 severe anxiety (Spitzer et al., 2006).  A random sample of 
965 patients in family practice and internal medicine clinics were given the GAD-7 
followed by structured interviews with a clinical psychologist or senior psychiatric social 
worker.  The study found 89% of patients who scored >10 were diagnosed with 
Generalized Anxiety Disorder (GAD) and 82% of participants who scored <10 did not 
have GAD (Spitzer et al., 2006). The GAD-7 has been translated into multiple languages 
and is publicly available. In this sample the Cronbach alpha was α= .91. 
Stigma  
Stigma of mental illness was measured by the City MISS, an instrument designed 
to measure the stigma specific to PMAD. This is a new instrument first described and 
published by Moore and colleagues in 2017. Scale items were derived directly from 
women’s experiences of stigma in the literature. The instrument is a 15-item, 4-point 
Likert scale through which participants rate questions from strongly disagree to strongly 
agree.  Scores range from 1, indicating lower stigmatizing beliefs, to 15, indicating higher 
stigmatizing beliefs.  The City MISS instrument is composed of three subscales 
measuring three aspects of stigma: internal stigma, perceived external stigma, and 
disclosure stigma. Internal stigma is the internalization of beliefs that a mother with 
mental illness will be thought of as a bad mother.  There are five items in the internal 
stigma subscale; for example, “I can’t cope as well as I’d like with my baby.” Perceived 
external stigma is what the participant believes others think about a mother’s ability to 
fulfill their role as a mother when they have psychological issues. The subscale contains 




abnormal.” Disclosure stigma is the stigma related to expected discrimination if the 
participant discloses mental illness to others. There are four items in the disclosure 
subscale; for example, “I worry that if I told a health care provider about my 
psychological problems, my baby would be taken away.” Cutoff scores have not yet been 
designated for this instrument or the subscales to delineate low, moderate, or high levels 
of perinatal mental illness stigma. Psychometrics indicate the internal consistencies for 
the subscales are adequate: α = 0.84 for total scale, α = 0.86 for perceived external 
stigma, α = 0.81 for internal stigma, and α = 0.85 for disclosure stigma (Moore et al., 
2017).  The City MISS is not yet available in languages other than English and was 
utilized by permission from the developers. In this sample the Cronbach alpha was α=.88. 
Social Support  
Social support was measured using the Multidimensional Scale of Perceived 
Social Support (MSPSS).  Zimet and colleagues (1988) first published this 12-item, 7-
point Likert scale instrument in 1988. It is designed to measure perceptions of support 
from family, friends, and a significant other. According to the instrument developers, a 
mean total score ranging from 1-2.9 indicates low support, 3-5 indicates moderate 
support, and 5.1-7 indicates high support (Zimet et al., 1988).  The instrument has three 
subscales corresponding with the three areas of support. Cronbach’s alpha scores are as 
follows: 0.88 for the total scale, 0.91 for the significant other subscale, 0.87 for the family 
subscale, and 0.85 for the friends subscale.  The MSPSS has been translated into many 




Treatment Seeking Definition 
Positive treatment-seeking after discharge was defined by this researcher as 
having scheduled or attended mental health treatment including postpartum depression or 
anxiety support group or seeing a mental health professional such as a psychiatrist, 
psychologist, or therapist. 
Admission Screening Variables 
A report generated from admission screening questions was used to evaluate the 
level of agreement between the current admission screen and interview screen using the 
EPDS and GAD-7. Admission screening questions were as follows: 1) Do you have a 
history of depression, anxiety, or another mental health diagnosis? 2) During your 
pregnancy, have you felt depressed or anxious to a degree that seemed unusual? 3) In the 
recent past, have you had any thoughts of harming yourself or others?  
 
Table 1.  
Variables and operational definitions 
Variables Operational Definition 
Age (categorical) Age in years, 18 or older  
Race/ethnicity (categorical) Self-identifies as White, Black, Hispanic, 
Asian/Pacific Islander, Multi-ethnic 
Marital status (categorical) Married, Cohabitating, Unpartnered 
Parity (categorical) Primapara or multipara 
Primary language (categorical) Self-identifies as English, Spanish, Other 
Planned or unplanned pregnancy (categorical) Pregnancy was planned, desired versus pregnancy 






(categorical for Group A <10, Group B>10) 
Depressive symptoms 0-30 possible 
0-8 low probability of depression/anxiety 
9-10 moderate/possible depression/anxiety 
>12 high/probable depression/anxiety 
GAD-7  
(categorical for Group A <10, Group B>10) 
Anxiety symptoms 0-21 possible 
0-4 minimal anxiety 
5-9 mild anxiety 
10-14 moderate anxiety 
15-21 severe anxiety 
MSPSS score (continuous) 7-point Likert scale=1 (very strongly disagree) to 
7 (very strongly agree) 
MISS score (continuous) 4-point Likert scale = 1 (strongly disagree) to 4 
(strongly agree) 
Treatment seeking Yes – scheduled, planned, or ongoing support 
group, visit with a mental health professional 
No- no follow up planned 
 
Data Analysis Plan 
Descriptive and inferential statistics were used in this study. All study variables 
were examined for normality, missing values, and outliers. Summary statistics were 
calculated including frequencies for categorical variables and means with standard 
deviations (SD) for continuous variables. Bivariate associations were examined with chi-
squared analysis for categorical variables and correlations for continuous variables. A 
correlation matrix was constructed to identify the potential for multicollinearity. 




logistic regression model to identify factors that increase the likelihood of treatment-





Chapter IV  
Results 
The purpose of this study was to examine the relationships among PMAD 
symptomatology, select demographics, stigma of mental illness, and social support 
among a sample of postpartum women on a mother-infant dyad care unit.  The results 
presented in this chapter include a descriptive profile of the sample followed by results 
related to the specific aims and research questions. 
Aim 1. Characterize a cohort of inpatient postpartum women participating in mother-
infant dyad care. 
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support, 
and select demographics among a cohort of inpatient postpartum women. 
Aim 3. Assess treatment seeking in women with PMAD symptomatology after discharge 
from the hospital.   
Participants 
Aim 1. Characterize a cohort of inpatient postpartum women participating in 
mother-infant dyad care. 
A convenience sample of 105 English and Spanish speaking women was recruited 
and enrolled from a Southern California woman’s specialty hospital postpartum unit, 
between July 2018 and August 2018.  Mothers had given birth 24 or more hours prior to 
recruitment. Mothers were not included if they were separated from their infants.  Study 
instruments were administered in English and Spanish based on the individual’s stated 
primary language in the electronic medical record and participant preference.  A 




The demographic characteristics of the sample are summarized in Table 2.  
Comparisons were made between those scoring <10 on the EPDS or GAD-7, referred to 
as Group A, and those scoring >10 on the EPDS or GAD-7, referred to as Group B. The 
mean age (and SD) for the combined group was 30.8+5.02 (range 18-46).  Mean years of 
education were 15.2+3.2 (range 0-23), and mean previous births were 1+1.06 (range 0-4).  
Groups A and B were similar in terms of ethnicity and primary language with 46% of 
participants in Group A and 43.8% in Group B self-identified as Hispanic; English was 
the primary language (73.6% in Group A, 75% in Group B).  None of these differences 
were statistically significant. Pregnancy was planned for 72.8% of the groups combined 
with slightly higher rates (74.7%) in Group A as compared to 62.5% in Group B.  Less 
than half (46.5%) of both groups combined had planned or unplanned Cesarean sections 
with higher rates in Group B (68.8%) as compared to Group A (42.5%).  A higher 
percentage of participants in Group A were married (73.6%) compared to Group B 
(50%); 4.6% of Group A was single and not living with the father of the baby compared 
to 25% of Group B (p=.01).  Although there were significant differences between groups 
for marital status, there were no significant differences for language, ethnicity, planned 
pregnancy, or type of delivery. Regarding prior history of depression and anxiety, 36% of 
participants reported some mental health history (n=33); however, because the 
demographic survey did not include an option for no history, it is not possible to 
determine the number of participants with no history as compared to those who did not 
answer the question. The sample size for Group B was small (n=16), limiting sufficient 








Group A  
(+ SD) 
Mean 








Age 30.8+5.1 30.4+4.8 18-46 30.8+ 5.02 0.05 0.82 
Years Education 15.4+2.9 14.4+4.7 0-23 15.2+3.2 1.51 0.22 
Previous births 1.02+1.0 .88+1.2 0-4 1+1.06 0.26 0.61 
  
      




Language     0.26 1.00 
 English 64 (73.6%) 12 (75%)  76 (70%)   
 Spanish 18(20.7%) 3(18.8%)  21(19.1%)   
 Other 5(5.7%) 1(6.3%)  6(6.4%)   
Race/Ethnicity     3.2 0.48 
 Hispanic 40 (46%) 7 (43.8%)  47 (43.6%)   
 Black 3 (3.4%) 1 (6.3%)  4 (3.6%)   
 White 28 (32.2%) 6 (37.5%)  34 (30.9%)   
 Asian 10 (11.5%) 0(0%)  10 (10%)   
 Multi-ethnic 6 (6.9%) 2(12.5%)  8(7.3%)   
Marital Status     6.95 0.01 
 Married 64 (73.6%) 8 (50%)  72 (69.9%)   
Single, living with father 
of the baby 
19 (21.8%) 4 (25%)  23 (22.3%)   
Single, not living with 
father of the baby 
4 (4.6%) 4 (25%)  8 (7.71%)   
Pregnancy     1.38 0.35 
 Planned 65 (74.7%) 10 (62.5%)  75 (72.8%)   
 No planned 20 (23%) 6 (37.5%)  26 (25.2%)   
 Missing 2 (2.3%) 0  2(1.9%)   
Type of delivery     4.42 0.10 
 Vaginal 50 (57.5%) 5 (31.3%)  55 (53.3%)   




 Unplanned C section 16 (18.4%) 6 (37.5%)  22 (21.3%)   
Mental health history       
 Depression 3 0  3   
 Anxiety 11 4  15   
Both depression and 
anxiety 
6 5  11   
 Other (i.e. bipolar) 3 1  4   
No answer 53 6  59   
 
 
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support, 
and select demographics among a sample of inpatient postpartum women. 
As described in Table 3, the mean EPDS score for the combined group in this 
study was 4.7 +3.9, and the mean GAD-7 score was 3.9+4.2. The mean total score on the 
City MISS was 1.5+.4, and the scores on the three subscales were as follows: internal 
stigma (IS) 1.1+.2, external stigma (ES) 1.9+.7, and disclosure stigma (DS) 1.4+.7.  The 
mean MSPSS score was 6.4+.9 indicating overall high support.  Mean scores for the 
subscales were 6.6+.9 for the significant other subscale, 6.3+1.1 for the family subscale, 
and 6.2+1.3 for the friends subscale.  
The total sample consisted of 105 participants; missing values resulted in an 
analysis sample of 103.  Participants were separated into two groups: 87 (85%) scored 
<10 on the EPDS or GAD-7 Group A; 16 (15%) scored 10 or higher on either the EPDS 
or GAD-7 Group B.  Significant differences between groups were noted for all study 
instruments’ summary scores and subscales: EPDS, GAD-7, City MISS, City Internal 




Other subscale, MSPSS Family subscale, MSPSS Friends subscale.  The EPDS and 
GAD-7 scores were significantly higher in Group B than Group A indicating higher 
depression and anxiety symptomatology (p<.001).  The overall City MISS score was 
significantly higher in Group B than Group A (p=.002) indicating higher overall stigma 
in the group with higher depression and anxiety symptomatology.  Scores on all three 
City MISS subscales were significantly higher for Group B than Group A indicating 
higher levels of internal stigma (p<.001), external stigma (p=.03), and disclosure stigma 
(p=.02). Overall MSPSS score was significantly lower in Group B indicating lower 
overall social support in the group with higher depression and anxiety symptomatology 
(p<.001). The scores on all three MSPSS subscales were significantly lower in Group B: 
significant other subscale (p=.003), family subscale (p=.03), and friends subscale (p=.02) 
indicating lower levels of social support from all three categories in the group with higher 
depression and anxiety symptomatology.   
 
Table 3 











F statistic P-value 
EPDS 4.7+3.9 0-21 3.57+2.4 11+4.6 91.2 <.001 
GAD-7 3.9+4.2 0-21 2.7+2.4 10.5+5.7 83.5 <.001 
City MISS 1.5+.4 1-15 1.5+.4 1.84+.4 10.2 .002 
City MISS IS 
subscale 
1.1+.2 1-2 1.1+.1 1.3+.3 21.1 <.001 
City MISS ES 
subscale  






1.4+.7 1-3 1.39+.6 1.8+.7 5.9 .02 
MSPSS 6.4+.9 1-7 6.54+.89 5.64+.9 13.5 <.001 
MSPSS Significant 
Other  subscale 
6.6+.9 1-7 6.74+.87 6.04+.8 8.9 .003 
MSPSS Family 
subscale 
6.3+1.1 1-7 6.49+1.03 5.6+1.2 9.4 .003 
MSPSS Friends 
subscale 
6.2+1.3 1-7 6.38+1.14 5.3+1.8 10.3 .002 
 
Correlations among demographic variables are presented in Table 4.   Significant 
positive correlations were found between years of education and age (r= .28, p=.01), 
previous births (r=.27, p=.01), and total MSPSS score (r=.32, p=.01), respectively. 
Significant positive correlations for study variables are presented in Table 5 and were as 
follows: EPDS and IS (r=.55, p=.01), ES (r=.34, p=.01), and DS (r=.23, p=.01) indicating 
a higher level of all three dimensions of stigma with higher depression and anxiety 
symptomatology.  Significant correlations were found between EPDS and GAD-7 (r=.67, 
p=.01) supporting the close relationship between depression and anxiety found in the 
literature.  Significant correlations were found between EPDS and total MISS score 
(r=.40, p=.01), indicating a higher level of perinatal mental illness stigma with higher 
depressive symptomatology.  Significant correlations between EPDS and age, level of 
education, and previous births were not found in this study.  Similarly, relationships 
between EPDS and ethnicity, language, marital status, planned pregnancy, and type of 





Table 4  
Correlations for Demographic Variables 
Variables Age Ed Prev 
births 









Age  .28** -.004 .02 -.04 .06 .13 .06 .01 -.02 
Yrs of ed .28**  -.27** -.06 .04 -.05 .11 -.06 -.06 .32** 
Prev 
births 
-.004 -.27**  -.11 -.034 -.06 -.15 .03 -.16 .06 
**=correlation is significant at the 0.01 level (two-tailed) 
Table 5 
Correlations for Study Variables 
Variables Age Ed Prev 
births 













.02 -.06 -.11  .67** .40** .55** .34** .23* -.28** 
Total 
GAD-7 
-.04 .04 -.034 .67**  .42** .40** .38** .23* -.27** 
Total City 
MISS 








.06 -.06 .03 .34** .38** .92** .29*  .47** -.08 
Disclosure 
subscale 
.005 -.06 -.16 .23* .23* .76** .26** .47**  -.24* 
Total 
MSPSS 
-.02 .32** .06 -.28** -.27** -.18 -.21* -.08 -.24*  





Aim 3. Assess treatment seeking in women with PMAD symptomatology after discharge 
from the hospital.   
A cut point of 10 was chosen for both instruments to indicate possible depression 
or anxiety.  A score of 10 or greater is an indication of possible depression, and a positive 
response to Question 10 on the EPDS is indicative of possible suicidal thoughts (Cox et 
al., 1987). A cut point of 10 on the GAD-7 is used to represent a moderate level of 
anxiety (Spitzer et al., 2006). Of the 16 participants who scored >10 on the EPDS or 
GAD-7, four had a positive response by answering “hardly ever” to Question 10 on the 
EPDS. All denied current thoughts of self-harm or suicidal ideation when visited by a 
social worker.  Of the 12 who scored 10 or higher on the EPDS, three also scored 10 or 
higher on the GAD-7 indicating possible coexistence of depression and anxiety.  Four 
participants scored 10 or higher on the GAD-7 but did not have a score >10 on the EPDS, 
possibly indicating anxiety without depression.   
Treatment seeking information is listed in Table 6.  Providing a phone number 
was voluntary and 6 of the 16 with scores >10 on either instrument chose not to provide a 
phone number. Ten participants provided phone numbers and follow-up information was 
obtained for six. Four did not answer the telephone after three or more attempts or had a 
non-working phone number.  Of the six who were reached by telephone, four (66%) 
responded negatively to treatment-seeking.  One with a score of 16 on the GAD-7 
requested information about the hospital’s free PMADs support group. Two stated they 
were doing well, did not report depressive symptoms, and were not seeking treatment. 
These two participants had lower scores on the EPDS and low scores on the GAD-7, 11 




interested in treatment; however, she did not return phone calls made by the social 
worker for referrals. Two participants (33%) responded positively to treatment-seeking; 
they were either in treatment or had visits with health professionals scheduled. The 
sample size for treatment-seeking follow-up was very small and it was not possible to 
contact all 16 study participants with PMAD; 33% were seeking treatment, and 66% had 
not sought treatment at the time of the phone call.  
 
Table 6  
Treatment-Seeking Follow-Up 







6 7 16 2.66 4.75 Y N Interested in 
support group 
7 12 5 1.05 5.83 N   
11 18 21 2.06 4.58 Y Y  
30  5 13 1.73 5.66 N   
34 11 6 1.6 6.66 N   
38 11 7 Missing 5.33 Y N No symptoms 
44 13 4 1.6 5.41 N   
50 21 21 2.0 7.0 N  Seen by Social 
Worker in 
hospital 
51 10 8 1.86 4.5 N   
53 10 9 1.66 5.83 N   
55 11 7 2.2 5.33 Y Y Appt 
scheduled 
63 15 14 2.2 5.33 Y N Phone contact, 
referred to 
Social Worker 
73 8 14 1.73 6.75 N  No answer x3 




15S 10 4 1.73 4.08 N  No answer x3 
18S 2 14 1.4 6.58 N  Number not 
reachable 
An additional finding was related to comparisons between a report with screening 
results pulled from the electronic medical record during the study period and screening 
from study instruments. Admission screening questions included the following:  
1) Are you worried about taking care of yourself and/or your baby when you are 
discharged home and would you like to discuss this with someone?  
2) Do you have any history of depression, anxiety, or another mental health diagnosis?  
3) During your pregnancy, have your felt depressed or anxious to a degree that seemed 
unusual? 
4) In the recent past, have you had any thoughts of harming yourself or others?  
When the case data were examined for the period of this study (July 27, 2018 to 
August 30, 2018), the results indicated 16% reported a history of depression, anxiety, or 
other mental health diagnosis.  Regarding depressive symptomatology during pregnancy, 
5% of the cases reported feeling depressed or anxious to a degree that seemed unusual 
during the pregnancy.  Thoughts of self-harm were expressed by 0.8% of the cases. In 
this study, participant data was not matched with the patients included in this report; 
however, it is noteworthy that admission screening resulted in lower positive responses to 
depression and anxiety screening.  More than one third (36%) of study participants 
reported a history of depression, anxiety, or other mental health diagnosis and 15% of 
participants scored 10 or higher on the EPDS or GAD-7 indicating depression or anxiety 
symptomatology.  Although participants denied current thoughts of self-harm when 




thoughts of self-harm. These findings, although exploratory, support the need to utilize 
standardized screening instruments.   
Summary 
 In comparing Group A (those scoring <10 on the EPDS or GAD-7) and Group B 
(those scoring >10), there were no significant differences in age, years of education, 
previous births, language, ethnicity, planned pregnancy, or type of delivery.  Because the 
demographic survey did not include an option to indicate that they did not have a history 
of depression, anxiety, or other mental health diagnosis, a comparison cannot be made 
regarding mental health history.  Significant differences were noted between groups 
regarding marital status with more participants in Group A being married while Group B 
participants were more likely to be single. Significant positive correlations were found 
among groups for all study instruments and subscales: EPDS, GAD-7, City MISS, City 
Internal subscale, City External subscale, City Disclosure subscale, MSPSS, MSPSS 
Significant Other subscale, MSPSS Family subscale, and MSPSS Friends subscale.  In 
the post-discharge follow-up with patients with high depression and anxiety 
symptomatology, six were reached by telephone approximately one month after 
discharge and 33% sought mental health treatment while 66% had not sought mental 
health treatment. The current hospital admission screening identified less positive screens 
for history of depression, anxiety, and other mental health history, as well as less positive 
screens for thoughts of self-harm as compared to the study instruments, supporting the 





Discussion of Findings 
The purpose of this study was to examine the relationships among demographic 
factors, stigma of mental illness, levels of social support, PMAD symptomatology, and 
treatment-seeking in a sample of postpartum women in a women’s community hospital.  
Additionally, a comparison was made between the hospital’s existing admission 
depression and anxiety screening during the study time period and results from study 
instruments. Goffman’s (1963) and Corrigan’s (2004) concepts of stigma provided 
underpinnings for this research. The work of Zimet and colleagues (1988) regarding the 
role of social support in potentially mitigating the effects of stigma provided an 
additional framework for this study. In this chapter, a discussion of the findings and 
implications for nursing practice, education, research, and policy are presented.  
Study Summary 
Data were collected from a purposive sample of 105 inpatient postpartum mothers 
who gave birth between July 2018 and August 2018 in a 208-bed free-standing women’s 
community hospital located in a large Southern California metropolitan area. The mean 
age for the combined group was 30.7+5.02 (range 18-46).  Mean years of education were 
15.22+3.2 and mean previous births was 1+1.06. Comparisons were made between those 
scoring <10 on the EPDS or GAD-7, referred to as Group A, and those scoring >10 on 
the EPDS or GAD-7, referred to as Group B.  Groups A and B were similar in terms of 
ethnicity and primary language with 46% of participants in Group A and 43.8% in Group 
B self-identified as Hispanic, followed by 32.2% White in Group A and 37.5% White in 




Approximately two thirds of the 105 participants (69.9%) were married; a higher 
percentage of participants in Group A were married (73.6%) as compared to Group B 
(50%). This difference was significant (p=.01) and an association between unpartnered 
status and depression has been supported in the literature (Ertel et al., 2011).  
There were no significant differences between Group A and Group B in terms of 
age, education, previous births, language, ethnicity, type of delivery, or planned 
pregnancy.  Pregnancy was planned for 72.8% of the groups combined with slightly 
higher rates (74.7%) in Group A, as compared to 62.5% in Group B (p=.35). An 
increased risk of depression with unintended pregnancy has been supported in the 
literature; however, this difference may not have been observed in this study as a result of 
the sample size (Rich-Edwards et al., 2006). Regarding prior history of depression and 
anxiety, 36% of total participants reported some mental health history, 64% reported no 
history or no answer.  Because it was not possible to determine if no answer indicated no 
history or simply no answer, a comparison between groups for history of depression, 
anxiety, or other mental health diagnosis was not conducted.  
The prevalence of total participants scoring >10 on the EPDS (15%) was 
consistent with rates reported in the literature of 11-21.9% (Mayberry et al., 2007; Wisner 
et al., 2013).  Significant differences were found between Group A and Group B for total 
EPDS score and GAD-7 score (p<.001) supporting the frequent comorbid relationship 
between depression and anxiety identified in the literature (Wisner et al., 2013). 
Significant differences were found between groups for the total City MISS score (p=.002) 
as well as the three subscales: internal subscale (p<.001), external subscale, p=.03) and 




EPDS and GAD-7 (p=.01) and between all three City stigma subscales: IS (p=.01), ES 
(p=.01), and DS (p=.05). Mean scores for the total MSPSS Scale, MSPSS Significant 
Other Subscale, MSPSS Family Subscale, and MSPSS Friends Subscale scores were 
significantly different between Group A and Group B, with p values <.001, .003, .003, 
and .002 respectively supporting existing literature on the variation in social support with 
depressive symptomatology; higher rates of depression are associated with lower levels 
of social support (Webster et al., 2011). A number of relations among demographic 
variables, depressive symptomatology, stigma, and social support were not significant.  
For example, relations among demographic variables and the internal and disclosure 
stigma subscales and between EPDS and age, level of education, previous births, 
ethnicity, language, marital status, planned pregnancy, and type of delivery were not 
significant.  Similarly, relations between EPDS and ethnicity, language, marital status, 
planned pregnancy, and type of delivery were not significant.  
Telephone follow up one month after discharge indicated that 33% of participants 
in Group B sought mental health treatment; whereas, 66% in this group had not sought 
treatment. The current hospital screening process identified fewer patients at risk for 
depression, anxiety and self-harm; the process identified 16% with a history of 
depression, anxiety, or other mental health diagnosis, 5% feeling depressed or anxious to 
a degree that seemed unusual, and 0.8% with thoughts of self-harm.  This was in contrast 
to the study findings of 36% with a history of depression, anxiety, or other mental health 
diagnosis, 15% with PMAD symptomatology, and 3.8% of participants with thoughts of 




instrument as recommended by the American College of Obstetricians and Gynecologists 
ACOG, 2015).  
Nursing Implications 
Nursing Practice 
The findings of this study add to the body of literature describing the relationships 
among depression and anxiety, stigma, and social support.  It was notable that the 
existing screening process identified far fewer patients than the study screening 
instruments supporting existing literature on the benefits of utilizing valid and reliable 
screening instruments (ACOG, 2018, Evans et al., 2015). Further examination is needed 
regarding the current hospital admission screening process including the timing of 
screening, whether the questions are asked when family members are in the room, and the 
way the screening is approached. Hospital nurses play a key role as members of the inter-
professional team by screening patients for PMADs.  Patients should be screened in 
private, in a non-judgmental way, when they are not in pain with active labor, and with a 
standardized, validated instrument.  The ideal instrument will have been validated with 
inpatient postpartum women from diverse cultures.  When at-risk patients are identified, 
nurses are well-suited to educate them on the signs, symptoms, and referral resources for 
PMADs and refer them to additional resources such as in-house social workers and 
outpatient counseling. Because screening may not occur after discharge or it may not be 
conducted in accordance with symptoms, screening and education during the inpatient 
stay may be very beneficial. Nurses can help familiarize all patients with signs, 





Nurses and other health professionals may benefit from ongoing education 
regarding PMAD risk factors, screening methodology, referral resources, as well as the 
relationships between depression, anxiety, stigma, and social support.  Investigators on 
the United States Preventive Services Task Force reviewed 50 studies on interventions to 
decrease the risk of depression during pregnancy and the postpartum period.  One of the 
key findings is that counseling can help prevent depression in women at increased risk 
(O'Connor, Senger, Henninger, Coppola, & Gaynes, 2019).  With a greater understanding 
of the relationships between depression, anxiety, stigma, and social support, when 
patients are identified at risk for PMAD nurses can help to address the stigma of mental 
illness, help to ensure patients have adequate social support, and refer them to appropriate 
resources.  
Limitations 
This study has several limitations.  The overall sample size was small, and as a 
result, the size of Group B (EPDS and GAD-7>10) was small (n=16).  As a result, there 
was insufficient power to conduct a logistic regression.  The study was also conducted 
during 1 month in the summer and may not be representative of other periods during the 
year. The demographic survey did not include an option for patients with no mental 
health history as compared to participants who did not answer the question.  As a result, a 
statistical comparison could not be made between participants with a mental health 
history and those without. Providing a phone number for treatment-seeking follow-up 
was voluntary and because only 10 of the 16 in Group B provided phone numbers, it was 




16.  Four participants who provided phone numbers could not be reached further limiting 
the information that could be obtained about treatment-seeking. Further study is needed 
regarding the actual treatment of women with PMADs in relation to their ratings of 
stigma and social support. 
The sample was limited to English- and Spanish-speaking patients and may not be 
representative of individuals from different cultures or who speak other languages.  Signs 
and symptoms of PMADs can appear at any time during the perinatal period and because 
study instruments were administered approximately 24 hours after delivery, EPDS or 
GAD-7 scores could be less accurate than if the screening occurred at several intervals 
during the postpartum period. For example, a participant with a score >10 on the EPDS 
could potentially be experiencing transient depressive symptoms, or a participant with a 
score <10 could develop symptoms in the weeks and months post-discharge. In addition, 
both the EPDS and GAD-7 are screening instruments and are not diagnostic; therefore, 
further evaluation of screened individuals is needed to diagnose depression or anxiety. In 
the immediate postpartum period there are many interruptions and participants may have 
been fatigued, thus affecting the ratings on the study instruments. The majority of studies 
utilizing the EPDS and GAD-7 have been conducted in an outpatient setting, rather than 
an inpatient one, and more ideal screening instruments for the immediate postpartum 
period are not yet available.  
This study did not examine aspects of stigma and social support in depth and to 
protect the privacy of participants, personal identifying information was not collected.  
As a result, participants’ medical records were not accessed and answers to admission 




examine the concordance of current admission depressive screen and study instruments, 
access to participants’ medical records would be required.  
Despite the noted limitations, this study adds to the body of knowledge regarding 
risk for PMADs in postpartum patients and further clarifies the relationships among 
PMAD symptomatology, stigma, and social support. Future research is needed to further 
understand the relationships among the stigma of mental illness, social support, PMADs, 
and treatment-seeking in postpartum women as well as more research on the specific 
dimensions of stigma and interventions to address overcoming barriers to treatment in 
this patient population.  
Conclusion 
The perinatal period is a high-risk period during which as much as 21% of women 
may suffer from PMADs and lead to potential adverse effects on the entire family.  The 
absence or inconsistency of screening and the stigma of mental illness contribute to less 
than half of women with PMADs being identified and treated.  Strong social support may 
mitigate the effects of stigma and may play a significant role in the identification and 
treatment of women with PMAD. This study examined the relationships among 
demographic variables, PMAD symptomatology, stigma, and social support, and shed 
light on barriers to the identification and treatment of women with PMADs. This study 
contributes to the nursing profession by highlighting the prevalence of PMADs, impact 
on families, ongoing barriers to identification and treatment, and by highlighting gaps in 
the existing hospital screening process as compared to screening utilizing valid, reliable 
instruments, thereby providing the basis for implementing standardized screening in the 
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Study Title: Perinatal Mood and Anxiety Disorders: Impact of Stigma and Social Support on 
Treatment-Seeking 
Dear Patient: 
You are being asked to participate in a research study conducted by Ellen K. Fleischman, 
PhD student at the University of San Diego. The purpose of this study is to answer the 
following questions: What is the relationship between stigma, perinatal mood and anxiety 
disorders (focusing on depression and anxiety), and social support? When mothers suffer 
from these disorders, how do stigma and social support affect the decision to seek 
treatment for depression and anxiety?  Approximately 100 patients on the Maternal Infant 
Services Unit will take part in this study at Sharp Mary Birch Hospital for Women & 
Newborns. 
Your participation in this study involves a one-time completion of several questionnaires: 
the 10-question Edinburgh Postnatal Depression Scale (EPDS), 15-question City Mental 
Illness Stigma Scale (City MISS), 12-question Multidimensional Measure of Perceived Social 
Support (MSPSS), 7-question Generalized Anxiety Disorder Scale (GAD-7), and a 
demographic questionnaire. Your participation is expected to last approximately 15-20 
minutes.  You will be provided with resources related to depression and anxiety in case you 
would like further information.  If your scores on the study instruments indicate you may 
have some difficulty with depression or anxiety we would like to contact you, with your 
permission, after discharge, to discuss available resources.  
Risks and Benefits: There are no anticipated risks for participating; however, some patients 
may feel uncomfortable when answering some of the questions on the surveys, as the 
questions may cause you to reflect on your feelings. However, your participation may be of 
benefit because the surveys may prompt you to ask some important questions that you 
might not have thought of previously and provide more information on your overall 
wellness. We will try to make you as comfortable as possible when you are answering the 
questions. 
Your survey answers will be anonymous and will be identified by a study code known only to 
you and the investigator.  Your individual responses will not be shared with anyone at Sharp 
other than the investigator. Your individual responses will be aggregated with all other 
participants in the study. The aggregated data will be analyzed, and results will be shared 
with the University of San Diego and Sharp Mary Birch Hospital for Women & Newborns. 
Should you choose to have us contact you after discharge, there will be an option to include 
your phone number and e-mail address on a separate piece of paper that has your study 
code. The person making the discharge phone call will not have access to other information 
about you. Representatives of the Sharp HealthCare Institutional Review Board (IRB) may 
review the study at any time, (including your de-identified individual responses), to assure 




You will be compensated for your time with a $10 gift card upon completion of all surveys. If 
you wish to participate, your completion of the surveys will indicate that you have read 
this consent, have had a chance to ask questions, and that you consent to participate. 
Your participation in this study is completely voluntary, and if you do not wish to 
participate, you do not need to do anything further. If you start the surveys and decide 
not to finish, you can stop at any time. Please complete the attached surveys and return 
them in the attached envelope, either to the investigator or to your nurse.  
If you have any questions at any time, please feel free to contact Ellen K. Fleischman at 
ellen.fleischman@sharp.com or (858) 939-4174.  If you have any questions about your 
rights as a participant in research you may contact the Sharp HealthCare Institutional 
Review Board (IRB; a group of people who review research to protect the rights of research 
participants) at 858-939-7195. 
 
Thank you for your consideration. 
 
Ellen K. Fleischman, MSN, RN, RD, NE-BC 
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